Gavreto
Product Images NDC 50242-210

2 FDA label images from Genentech, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gavreto (NDC 50242-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gavreto 01)

Chemical Structure (Gavreto 01)
Chemical structure of the active ingredient in Gavreto, showing its detailed molecular framework including multiple heterocyclic rings and stereochemistry labels (cis and S). The diagram illustrates the molecular connectivity and stereochemical configuration relevant to the compound.*
FDA Label Image

Principal Display Panel (100 mg Bottle Label)

Principal Display Panel (100 mg Bottle Label)
Label for Gavreto (pralsetinib) capsules, 100 mg strength. The label indicates the medication is for oral use and is prescription only. The package contains 60 capsules. The labeler is Genentech, Inc., and the label also features the Blueprint Medicines logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.